Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56226 - 56250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	HIST1H2BK	85236	downregulated	panobinostat results in decreased expression of HIST1H2BK mRNA	6p22.1	A21037
Panobinostat	Approved Investigational	HK1	3098	upregulated	panobinostat results in increased expression of HK1 mRNA	10q22.1	A21037
Panobinostat	Approved Investigational	HLA-DMA	3108	upregulated	panobinostat results in increased expression of HLA-DMA mRNA	6p21.32	A21037
Panobinostat	Approved Investigational	HLA-DPB2	3116	upregulated	panobinostat results in increased expression of HLA-DPB2 mRNA	6p21.32	A21037
Panobinostat	Approved Investigational	HMGCLL1	54511	downregulated	panobinostat results in decreased expression of HMGCLL1 mRNA	6p12.1	A21037
Panobinostat	Approved Investigational	HMOX1	3162	upregulated	panobinostat results in increased expression of HMOX1 mRNA	22q12.3	A21037
Panobinostat	Approved Investigational	HNMT	3176	upregulated	panobinostat results in increased expression of HNMT mRNA	2q22.1	A21037
Panobinostat	Approved Investigational	HPDL	84842	upregulated	panobinostat results in increased expression of HPDL mRNA	1p34.1	A21037
Panobinostat	Approved Investigational	HPS1	3257	upregulated	panobinostat results in increased expression of HPS1 mRNA	10q24.2	A21037
Panobinostat	Approved Investigational	HRASLS5	117245	upregulated	panobinostat results in increased expression of HRASLS5 mRNA	11q12.3	A21037
Panobinostat	Approved Investigational	HRK	8739	upregulated	panobinostat results in increased expression of HRK mRNA	12q24.22	A21037
Panobinostat	Approved Investigational	HS3ST3B1	9953	downregulated	panobinostat results in decreased expression of HS3ST3B1 mRNA	17p12	A21037
Panobinostat	Approved Investigational	HSPA4L	22824	upregulated	panobinostat results in increased expression of HSPA4L mRNA	4q28.1	A21037
Panobinostat	Approved Investigational	HSPB11	51668	downregulated	panobinostat results in decreased expression of HSPB11 mRNA	1p32.3	A21037
Panobinostat	Approved Investigational	ICAM1	3383	upregulated	panobinostat results in increased expression of ICAM1 mRNA	19p13.2	A21037
Panobinostat	Approved Investigational	ICAM3	3385	upregulated	panobinostat results in increased expression of ICAM3 mRNA	19p13.2	A21037
Panobinostat	Approved Investigational	ID4	3400	upregulated	panobinostat results in increased expression of ID4 mRNA	6p22.3	A21037
Panobinostat	Approved Investigational	IDH3A	3419	upregulated	panobinostat results in increased expression of IDH3A mRNA	15q25.1	A21037
Panobinostat	Approved Investigational	IER3	8870	upregulated	panobinostat results in increased expression of IER3 mRNA	6p21.33	A21037
Panobinostat	Approved Investigational	IFI16	3428	upregulated	panobinostat results in increased expression of IFI16 mRNA	1q23.1	A21037
Panobinostat	Approved Investigational	IFI30	10437	upregulated	panobinostat results in increased expression of IFI30 mRNA	19p13.11	A21037
Panobinostat	Approved Investigational	IFITM1	8519	upregulated	panobinostat results in increased expression of IFITM1 mRNA	11p15.5	A21037
Panobinostat	Approved Investigational	IGDCC3	9543	upregulated	panobinostat results in increased expression of IGDCC3 mRNA	15q22.31	A21037
Panobinostat	Approved Investigational	IGF2	3481	upregulated	panobinostat results in increased expression of IGF2 mRNA	11p15.5	A21037
Panobinostat	Approved Investigational	IGFBP3	3486	downregulated	panobinostat results in decreased expression of IGFBP3 mRNA	7p12.3	A21037

Displaying entries 56226 - 56250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability